default author photo

Alessandra Longobardi

University of Naples Federico II

SCHOLARLY PAPERS

2

DOWNLOADS

269

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of Systemic Therapies Following Progression on CDK4/6 Inhibitors in Patients with HR+/HER2-- Metastatic Breast Cancer: A Systematic Review and Network Meta-Analysis

Number of pages: 35 Posted: 13 Jun 2025
Scuola Superiore Meridionale, Vanvitelli University of Campania Luigi Vanvitelli, University of Naples Federico II, Baylor College of Medicine, University of Milan, University of Padova, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), Sapienza University of Rome, Baylor College of Medicine, Harvard University - Dana-Farber Cancer Institute, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, Gustave Roussy, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda USL Toscana Centro - Sandro Pitigliani Translational Research Unit, University of Udine - Deparment of Medicine (DAME), University of Naples Federico II, Vanvitelli University of Campania Luigi Vanvitelli, IRCCS-Fondazione Bietti and Baylor College of Medicine
Downloads 146 (505,974)

Abstract:

Loading...

HR+/HER2- metastatic breast cancer, CDK4/6 inhibitor resistance, Systematic Review, Network meta-analysis, Biomarker-driven therapy, Antibody-drug conjugates

2.

Analysis of Artificial Intelligence Decision-Making in Hormone Receptor-Positive / Human Epidermal Growth Factor 2-Negative Early Breast Cancer within Routine Clinical Practice and Clinical Trial

Number of pages: 21 Posted: 26 Jun 2025
Scuola Superiore Meridionale, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, Gustave Roussy, University of Naples Federico II, Harvard University - Dana-Farber Cancer Institute, University of Naples Federico II, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, ASL Napoli 3 Sud, ASL Napoli 3 Sud, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, University of Milan, University of Naples Federico II, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), IRCCS-Fondazione Bietti, University of Naples Federico II, Baylor College of Medicine and University of Naples Federico II
Downloads 123 (584,619)

Abstract:

Loading...

Artificial intelligence, LLMs, genomic testing, Oncotype DX ®, decision making, early stage breast cancer